TFEB and chronic kidney disease: In spite of these limitations, this study’s findings do provide important new insights, including the downregulation of TFEB in CKD, the functional relationship between HDAC6 inhibition and TFEB activity and the reno-protective effects of HDAC6 inhibition by Tubastatin A.